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1. Introduction 
fl-Adrenergic agonists stimulate and a-adrenergic 
agonists inhibit pancreatic somatostatin release [ 11. 
Little is known about the adrenergic modulation of 
the gastric D-cell. Therefore, the response of gastric 
somatostatin to adrenergic agonists was investigated 
using an isolated, perfused rat stomach preparation. 
2. Materials and methods 
The experimental model of the isolated, perfused 
rat stomach has been described in [2]. Briefly, the 
stomach of fasted rats was isolated with vasculature 
intact by division at the pylorus. Pancreas, spleen, 
small bowel and colon were removed. Perfusate 
(Krebs bicarbonate buffer, containing 0.2% human 
serum albumin and 3% dextran (pH 7.4) gassed with 
95% O2 and 5% COz) was infused into the coeliac 
artery (3 ml/min). Portal vein effluent was collected 
in 1 min intervals. Adrenergic agonists were intro- 
duced into the perfusate via a side-arm. 
Somatostatin-like immunoreactivity (SLI) and 
immunoreactive gastrin were determined using the 
radioimmunoassays in [ 3,4]. Adrenergic stimulants 
used in this study did not crossreact with the anti- 
bodies. 
Isoproterenol was purchased from Serva, Heidel- 
berg; epinephrine and norepinephrine were obtained 
from Hoechst, Frankfurt/M. 
All data are expressed as mean f SEM. For 
statistical comparisons student’s f-test for paired data 
was used. 
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Fig. 1. Effect of isoproterenol on gastric somatostatin-like 
immunoreactivity (SLI) and immunoreactive (IR) gastrin 
release. (o . 0) Isoproterenol2 ng/ml (n=5); (0 - -0) 
isoproterenol 10 ng/ml (n=6); (m-m) controls (n=5). 
Asteriks indicate significant changes vs basal @ < 0.05). 
3. Results 
At 2 and 10 ngJml(9.5 and 47 nM), isoproterenol 
led to 2.5- and 8-fold increases in gastric SLI secre- 
tion, respectively (fig. 1). Epinephrine at 2 ng/mI 
(11 nM) did not influence gastric SLI release whereas 
at 10 ng/ml(55 nM) a 2.5-fold increase was observed 
(fig.2). Isoproterenol and epinephrine at the low 
concentration did not influence gastrin secretion 
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Fig.2. Effect of epinephrine on SLI and IR gastrin release. 
(0. . o) Epinephrine 2 ng/ml (n=5); (o-0) epinephrine 
10 ng/ml (n=S); (o - -0) controls (n=6). Asterisks indicate 
significant changes vs basal @ < 0.05). 
while at the high concentration an enhanced gastrin 
release was found but this increase was not significant 
(fig. 1,2). Norepinephrine (10 &ml = 59 nM) did not 
cause any change in the rate of gastric SLI and gastrin 
secretion (fig.3). 
Perfusion pressure changes induced by the sub- 
stances tested were small (< f 10 mm Hg). 
4. Discussion 
The present results indicate that /3-adrenergic 
agonists stimulate gastric SLI secretion whereas the 
a-adrenergic agonist norepinephrine in equivalent 
concentrations has no effect. The epinephrine levels 
used in this study are within, or slightly above, serum 
concentrations reached during exercise [S]. The 
concentrations reached locally following adrenergic 
nerve stimulation are unknown but are probably at 
least as high as blood levels. 
Gastric acid secretion in dogs has been shown to 
be inhibited by /I-adrenergic agonists [6-81 and 
stimulated by /I-adrenergic blockade [9]. In cats, 
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Fig.3. Effect of norepinephrine on SLI and IR gastrin release. 
(m-m) Norepinephrine 10 ng/ml (n=6); (0 . 0) controls 
(n=5). 
sympathetic nerve stimulation inhibited food- 
stimulated gastric acid secretion [lo]. Since 
exogenous somatostatin inhibits gastric acid secre- 
tion [ 111, these results could indicate that enhanced 
gastric SLI release induced by /3-adrenergic agonists is 
involved in the inhibition of gastric acid secretion. 
/3-Adrenergic stimuli cause an increase in gastrin 
secretion in vivo [12-141. Exogenous somatostatin 
inhibits gastrin release [ 111. Therefore, endogenous 
SLI released by /3-adrenergic stimulation could play 
a role in the regulation of the G-cell. The failure of 
isoproterenol and epinephrine to stimulate gastrin 
release significantly have may be due to the large 
amounts of SLI released by the denervated stomach 
preparation used, which attenuated gastrin release. 
Finally, /%adrenergic stimulating agents influence 
mucosal blood flow [ 151 and gastric motility [ 161 
both of which are affected by exogenous soma- 
tostatin [ 17,181. Therefore, the physiological role of 
SLI released from the stomach may involve a number 
of diverse functions. However, these results and the 
preliminary demonstration that post-prandial release 
of SLI is reduced by sympathectomy [ 191 provide 
evidence for an interplay between the sympathetic 
nervous system, release of SLI and the control of 
gastrointestinal function. 
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